Case Summary {#sec1-1}
============

The patient was born at 36 weeks gestational age to a 39-year-old multigravida after a pregnancy that was complicated by gestational diabetes. There was no significant family history. The patient was noted to have bilateral anophthalmia, choanal atresia, and bilateral cryptorchidism at birth. Magnetic resonance imaging of brain was performed and detected a large mass in the right frontal and parietal lobes with a cleft extending into the center of the lesion with the adjacent sulcal pattern that was suggestive of polymicrogyria. Magnetic resonance spectroscopy showed high choline suggesting hypercellularity. Repeat magnetic resonance imaging of brain at 1 month of age did not show any change \[Figures [1](#F1){ref-type="fig"}-[3](#F3){ref-type="fig"}\] but a third magnetic resonance imaging of brain at 7 months of age showed a decrease in the size of the mass. A magnetic resonance imaging study at 2 years and 1 month of age showed further decrease in the size of the mass \[Figures [4](#F4){ref-type="fig"}-[6](#F6){ref-type="fig"}\]. A single nucleotide polymorphism array revealed a previously known pathogenic mutation, a deletion of approximately 1 megabase on chromosome 3q26.33 containing six reference sequence genes including SOX2 (chromosomal microarray nomenclature: Arr3q26.33q26.33 (182,127,678-183,154,618) × 1. The child is now 2 years old and has intractable focal epilepsy; left sided hemiparesis; and global developmental delay with inability to sit and no vocalizations other than babbling.
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Discussion {#sec1-2}
==========

SOX2 is a member of the SOX family which consists of 20 genes in humans, each of which is defined by a sex determining region of the Y chromosome (SRY) related DNA binding domain that is highly conserved across eukaryotic species and known as the high mobility group (HMG) box.\[[@ref1][@ref2]\] SOX2 is expressed during various phases of embryonic development and plays a critical role in embryogenesis. It is a key regulator of neural progenitor identity and is required for stem cell maintenance in the central nervous system.\[[@ref3][@ref4]\] SOX2 gene mutations are inherited in an autosomal dominant manner but often arise *de novo* and are associated with anophthalmia, microphthalmia or less commonly anterior segment dysgenesis, optic nerve hypoplasia, cataract, coloboma, and retinal dysplasia.\[[@ref5][@ref6][@ref7][@ref8][@ref9][@ref10]\] Other associations include dysfunction of hypothalamo-pituitary axis, male genital abnormalities including micropenis and cryptorchidism, esophageal atresia, tracheoesophageal fistula, and choanal atresia.\[[@ref7][@ref8][@ref11][@ref12][@ref13]\] Neurologic manifestations reported in association include learning disability, delayed motor development, seizures, sensorineural hearing loss and brain malformations including agenesis and dysgenesis of corpus callosum, pituitary hypoplasia, hypothalamic hamartoma, mesial temporal periventricular heterotopia, and abnormally oriented and misshapen hippocampi.\[[@ref6][@ref7][@ref9][@ref10][@ref14]\] A single case of schizencephaly has been described with a SOX 2 missense variant that was inherited from a phenotypically normal father and not predicted to lead to loss of function.\[[@ref7]\] No neocortical malformations have been reported as an association. This case not only expands the spectrum of the phenotype of SOX2 gene mutations but also describes an evolution in an unusual cortical malformation with a spontaneous decrease in size, for which we do not have a good explanation from our review of literature.
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